deoxypyridinoline has been researched along with Benign Monoclonal Gammopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamond, TH; Golombick, T; Manoharan, A; Ramakrishna, R | 1 |
1 trial(s) available for deoxypyridinoline and Benign Monoclonal Gammopathies
| Article | Year |
|---|---|
Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.
Topics: Aged; Aged, 80 and over; Amino Acids; Antineoplastic Agents, Phytogenic; Biomarkers; Bone Remodeling; Creatinine; Cross-Over Studies; Curcumin; Disease Progression; Double-Blind Method; Female; Humans; Immunoglobulin Light Chains; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Myeloma Proteins; Parathyroid Hormone; Treatment Outcome; Vitamin D | 2012 |